Searchable abstracts of presentations at key conferences in endocrinology

ea0029p823 | Endocrine tumours and neoplasia | ICEECE2012

How clinical presentation of insulinoma is changing

Toaiari M. , Davi M. , Boninsegna L. , Falconi M. , Francia G.

Introduction: In 2009 the Endocrine Society’s clinical practice guidelines for management of hypoglycemic disorders, confirming previous suggestions, have stated that the new cut-off of insulin for the diagnosis of insulinoma should be lowed to 3 μU/mL in presence of hypoglycemia (serum glucose ≤55 mg/dL). Moreover hypoglycemia in post-prandial status has been reported in insulinoma, alone or associated with fasting hypoglycemia. Finally preexisting diabetes me...